Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis

References

• Akita H, Suzuki H, Hirohashi T, Takikawa H, Sugiyama Y. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharmacology Research 2002; 19: 34–41
   PubMed Web of Science ®Google Scholar
• Alme B, Sjovall J. Analysis of bile acid glucuronides in urine. Identification of 3 alpha, 6 alpha, 12 alpha-trihydroxy-5 beta-cholanoic acid. Journal of Steroid Biochemistry 1980; 13: 907–916
   PubMedGoogle Scholar
• Alpini G, Glaser S, Alvaro D, Ueno Y, Marzioni M, Francis H, Baiocchi L, Stati T, Barbaro B, Phinizy JL, et al. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. Gastroenterology 2002; 123: 1226–1237
   PubMedGoogle Scholar
• Alpini G, Glaser SS, Rodgers R, Phinizy JL, Robertson WE, Lasater J, Caligiuri A, Tretjak Z, LeSage GD. Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology 1997; 113: 1734–1740
   PubMedGoogle Scholar
• Alpini G, Ueno Y, Glaser SS, Marzioni M, Phinizy JL, Francis H, LeSage G. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 2001; 34: 868–876
   PubMedGoogle Scholar
• Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. Journal of Biology and Chemistry 2001; 276: 28857–28865
   PubMed Web of Science ®Google Scholar
• Anwer MS. Cellular regulation of hepatic bile acid transport in health and cholestasis. Hepatology 2004; 39: 581–590
   PubMed Web of Science ®Google Scholar
• Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiology Reviews 2001; 81: 1269–1304
   PubMed Web of Science ®Google Scholar
• Arrese M, Trauner M, Sacchiero RJ, Crossman MW, Shneider BL. Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter. Hepatology 1998; 28: 1081–1087
   PubMed Web of Science ®Google Scholar
• Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends in Molecular Medicine 2003; 9: 558–564
   PubMed Web of Science ®Google Scholar
• Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, et al. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. Journal of Biology and Chemistry 2004; 279: 22250–22257
   PubMed Web of Science ®Google Scholar
• Bachs L, Pares A, Elena M, Piera C, Rodes J. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1989; i: 574–576
   Google Scholar
• Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Molecular Cell Biology 1994; 14: 1544–1552
   PubMed Web of Science ®Google Scholar
• Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, Madejczyk MS, Li N. OSTalpha-OSTbeta: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 2005; 42: 1270–1279
   PubMed Web of Science ®Google Scholar
• Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood–brain barrier. Molecular Pharmacology 2004; 66: 413–419
   PubMed Web of Science ®Google Scholar
• Beato M, Herrlich P, Schutz G. Steroid hormone receptors: Many actors in search of a plot. Cell 1995; 83: 851–857
   PubMed Web of Science ®Google Scholar
• Becker M, Von Bergmann K, Rotthauwe HW, Leiss O. Effects of phenobarbital on biliary lipid metabolism in children with chronic intrahepatic cholestasis. European Journal of Pediatrics 1984; 143: 41–44
   PubMedGoogle Scholar
• Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. Journal of Biology and Chemistry 2000; 275: 16390–16399
   PubMed Web of Science ®Google Scholar
• Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochemistry and Biophysics Research Communications 2002; 293: 145–149
   PubMed Web of Science ®Google Scholar
• Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen ZS, Grinberg A, Westphal H, Klein-Szanto A, et al. Analysis of the in vivo functions of Mrp3. Molecular Pharmacology 2005; 68: 160–168
   PubMed Web of Science ®Google Scholar
• Berg JM. DNA binding specificity of steroid receptors. Cell 1989; 57: 1065–1068
   PubMedGoogle Scholar
• Berge Henegouwen GP, Brandt KH, Eyssen H, Parmentier G. Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. Gut 1976; 17: 861–869
   PubMedGoogle Scholar
• Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proceedings of the National Academy of Sciences. USA 1998; 95: 12208–12213
   PubMed Web of Science ®Google Scholar
• Bloomer JR, Boyer JL. Phenobarbital effects in cholestatic liver diseases. Annals of Internal Medicine 1975; 82: 310–317
   PubMed Web of Science ®Google Scholar
• Blumberg B, Sabbagh W, Jr, Juguilon H, Bolado J, Jr, Van Meter CM, Ong ES, Evans RM. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes and Development 1998; 12: 3195–3205
   PubMed Web of Science ®Google Scholar
• Bodin K, Bretillon L, Aden Y, Bertilsson L, Broome U, Einarsson C, Diczfalusy U. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: Evidence for involvement of cytochrome p450 3A4. Journal of Biology and Chemistry 2001; 276: 38685–38689
   PubMed Web of Science ®Google Scholar
• Bohan A, Boyer JL. Mechanisms of hepatic transport of drugs: Implications for cholestatic drug reactions. Seminars in Liver Disease 2002; 22: 123–136
   PubMed Web of Science ®Google Scholar
• Bossard R, Stieger B, O’Neill B, Fricker G, Meier PJ. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. Journal of Clinical Investigation 1993; 91: 2714–2720
   PubMed Web of Science ®Google Scholar
• Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T, Zollner G, Lee JY, Ballatori N. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. American Journal of Physiology and Gastrointestinal Liver Physiology 2006; 290: G1124–G1130
   PubMed Web of Science ®Google Scholar
• Boyer JL. Advancing the bile-ology of cholestatic liver disease. Hepatology 2001; 33: 758–759
   PubMedGoogle Scholar
• Bremmelgaard A, Alme B. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Scandinavian Journal of Gastroenterology 1980; 15: 593–600
   PubMed Web of Science ®Google Scholar
• Bremmelgaard A, Sjovall J. Bile acid profiles in urine of patients with liver diseases. European Journal of Clinical Investigation 1979; 9: 341–348
   PubMed Web of Science ®Google Scholar
• Bremmelgaard A, Sjovall J. Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis. Journal of Lipid Research 1980; 21: 1072–1081
   PubMed Web of Science ®Google Scholar
• Briz O, Romero MR, Martinez-Becerra P, Macias RI, Perez MJ, Jimenez F, San Martin FG, Marin JJ. OATP8/1B3-mediated cotransport of bile acids and glutathione: An export pathway for organic anions from hepatocytes?. Journal of Biology and Chemistry 2006; 281: 30326–30335
   PubMed Web of Science ®Google Scholar
• Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. Journal of Biology and Chemistry 1996; 271: 15091–15098
   PubMed Web of Science ®Google Scholar
• Bull LN, Van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, Klomp LW, Lomri N, Berger R, Scharschmidt BF, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nature Genetics 1998; 18: 219–224
   PubMed Web of Science ®Google Scholar
• Byrne JA, Strautnieks SS, Mieli-Vergani G, Higgins CF, Linton KJ, Thompson RJ. The human bile salt export pump: Characterization of substrate specificity and identification of inhibitors. Gastroenterology 2002; 123: 1649–1658
   PubMed Web of Science ®Google Scholar
• Cai SY, Boyer JL. FXR: A target for cholestatic syndromes?. Expert Opinion in Therapy Targets 2006; 10: 409–421
   PubMed Web of Science ®Google Scholar
• Cancado EL, Leitao RM, Carrilho FJ, Laudanna AA. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase. American Journal of Gastroenterology 1998; 93: 1510–1517
   PubMed Web of Science ®Google Scholar
• Carlton VE, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Human Molecular Genetics 1995; 4: 1049–1053
   PubMed Web of Science ®Google Scholar
• Carrella M, Feldman D, Cogoi S, Csillaghy A, Weinhold PA. Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin-treated rat. Hepatology 1999; 29: 1825–1832
   PubMedGoogle Scholar
• Castillo-Olivares A, Gil G. Suppression of sterol 12alpha-hydroxylase transcription by the short heterodimer partner: Insights into the repression mechanism. Nucleic Acids Research 2001; 29: 4035–4042
   PubMedGoogle Scholar
• Chambon P. The retinoid signaling pathway: Molecular and genetic analyses. Seminars in Cell Biology 1994; 5: 115–125
   PubMedGoogle Scholar
• Chen C, Staudinger JL, Klaassen CD. Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metabolism and Disposition 2003a; 31: 908–915
   PubMed Web of Science ®Google Scholar
• Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004; 126: 756–764
   PubMed Web of Science ®Google Scholar
• Chen F, Ma L, Dawson PA, Sinal CJ, Sehayek E, Gonzalez FJ, Breslow J, Ananthanarayanan M, Shneider BL. Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. Journal of Biology and Chemistry 2003b; 278: 19909–19916
   PubMed Web of Science ®Google Scholar
• Chen W, Chiang JY. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 2003; 313: 71–82
   PubMed Web of Science ®Google Scholar
• Chen W, Owsley E, Yang Y, Stroup D, Chiang JY. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. Journal of Lipid Research 2001; 42: 1402–1412
   PubMed Web of Science ®Google Scholar
• Cheng X, Buckley D, Klaassen CD. Regulation of hepatic bile acid transporters Ntcp and Bsep expression. Biochemistry and Pharmacology 2007; 74: 1665–1676
   PubMedGoogle Scholar
• Cheng X, Klaassen CD. Regulation of mRNA expression of xenobiotic transporters by the pregnane x receptor in mouse liver, kidney, and intestine. Drug Metabolism and Disposition 2006; 34: 1863–1867
   PubMed Web of Science ®Google Scholar
• Cherrington NJ, Hartley DP, Li N, Johnson DR, Klaassen CD. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. Journal of Pharmacology and Experimental Therapy 2002; 300: 97–104
   PubMed Web of Science ®Google Scholar
• Chianale J, Vollrath V, Wielandt AM, Amigo L, Rigotti A, Nervi F, Gonzalez S, Andrade L, Pizarro M, Accatino L. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochemistry Journal 1996; 314(Pt 3)781–786
   PubMedGoogle Scholar
• Chiang JY, Kimmel R, Weinberger C, Stroup D. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. Journal of Biology and Chemistry 2000; 275: 10918–10924
   PubMed Web of Science ®Google Scholar
• Chiang JY. Bile acid regulation of gene expression: Roles of nuclear hormone receptors. Endocrinology Reviews 2002; 23: 443–463
   PubMed Web of Science ®Google Scholar
• Chiang JY. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. American Journal of Physiology and Gastrointestinal Liver Physiology 2003; 284: G349–G385
   PubMed Web of Science ®Google Scholar
• Chiang JY. Regulation of bile acid synthesis: Pathways, nuclear receptors, and mechanisms. Journal of Hepatology 2004; 40: 539–551
   PubMed Web of Science ®Google Scholar
• Chignard N, Mergey M, Veissiere D, Parc R, Capeau J, Poupon R, Paul A, Housset C. Bile acid transport and regulating functions in the human biliary epithelium. Hepatology 2001; 33: 496–503
   PubMedGoogle Scholar
• Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. Journal of Biology and Chemistry 1997; 272: 23565–23571
   PubMed Web of Science ®Google Scholar
• Choi JH, Ahn BM, Yi J, Lee JH, Lee JH, Nam SW, Chon CY, Han KH, Ahn SH, Jang IJ, et al. MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenetics and Genomics 2007; 17: 403–415
   PubMed Web of Science ®Google Scholar
• Christie DM, Dawson PA, Thevananther S, Shneider BL. Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. American Journal of Physiology 1996; 271: G377–G385
   Google Scholar
• Cohen DE, Kaler EW, Carey MC. Cholesterol carriers in human bile: Are ‘lamellae’ involved?. Hepatology 1993; 18: 1522–1531
   PubMedGoogle Scholar
• Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005; 128: 297–303
   PubMed Web of Science ®Google Scholar
• Courtois A, Payen L, Guillouzo A, Fardel O. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Letters 1999; 459: 381–385
   PubMed Web of Science ®Google Scholar
• Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. American Journal of Physiology 1998; 274: G157–G169
   PubMed Web of Science ®Google Scholar
• Crestani M, Sadeghpour A, Stroup D, Galli G, Chiang JY. Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. Journal of Lipid Research 1998; 39: 2192–2200
   PubMed Web of Science ®Google Scholar
• Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Molecular Pharmacology 1999; 55: 929–937
   PubMed Web of Science ®Google Scholar
• Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. Journal of Biology and Chemistry 2001; 276: 9626–9630
   PubMed Web of Science ®Google Scholar
• Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990; 98: 1013–1016
   PubMed Web of Science ®Google Scholar
• Danielian PS, White R, Lees JA, Parker MG. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO Journal 1992; 11: 1025–1033
   PubMed Web of Science ®Google Scholar
• Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, Ballatori N. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. Journal of Biology and Chemistry 2005; 280: 6960–6968
   PubMed Web of Science ®Google Scholar
• De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M. The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. Journal of Biology and Chemistry 2001; 276: 30708–30716
   PubMed Web of Science ®Google Scholar
• De Fabiani E, Mitro N, Gilardi F, Caruso D, Galli G, Crestani M. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. Journal of Biology and Chemistry 2003; 278: 39124–39132
   PubMed Web of Science ®Google Scholar
• De Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, Deleuze JF, Desrochers M, Burdelski M, Bernard O, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proceedings of the National Academy of Sciences. USA 1998; 95: 282–287
   PubMed Web of Science ®Google Scholar
• Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiology Reviews 2006; 86: 849–899
   PubMed Web of Science ®Google Scholar
• Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O, Hadchouel M. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904–908
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Calderon PB, Taper HS, Roberfroid MB. Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: In vivo and in vitro studies. Toxicology Letters 1992; 61: 291–304
   PubMedGoogle Scholar
• Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. Journal of Hepatology 2004; 40: 585–591
   PubMed Web of Science ®Google Scholar
• Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, Karpen SJ. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001; 121: 140–147
   PubMed Web of Science ®Google Scholar
• Dilger K, Denk A, Heeg MH, Beuers U. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology 2005; 41: 595–602
   PubMed Web of Science ®Google Scholar
• Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, de Swiet M, Warnes G, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: Evidence for a defect in protein trafficking. Human Molecular Genetics 2000; 9: 1209–1217
   PubMed Web of Science ®Google Scholar
• Dolle P, Fraulob V, Kastner P, Chambon P. Developmental expression of murine retinoid X receptor (RXR) genes. Mechanisms in Development 1994; 45: 91–104
   PubMedGoogle Scholar
• Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 2001; 34: 351–359
   PubMed Web of Science ®Google Scholar
• Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Molecular Cell 2003; 11: 1079–1092
   PubMed Web of Science ®Google Scholar
• Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO Journal 1994; 13: 5370–5382
   PubMed Web of Science ®Google Scholar
• Dussault I, Beard R, Lin M, Hollister K, Chen J, Xiao JH, Chandraratna R, Forman BM. Identification of gene-selective modulators of the bile acid receptor FXR. Journal of Biology and Chemistry 2003a; 278: 7027–7033
   PubMed Web of Science ®Google Scholar
• Dussault I, Yoo HD, Lin M, Wang E, Fan M, Batta AK, Salen G, Erickson SK, Forman BM. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proceedings of the National Academy of Sciences. USA 2003b; 100: 833–838
   PubMed Web of Science ®Google Scholar
• Eggertsen G, Olin M, Andersson U, Ishida H, Kubota S, Hellman U, Okuda KI, Bjorkhem I. Molecular cloning and expression of rabbit sterol 12alpha-hydroxylase. Journal of Biology and Chemistry 1996; 271: 32269–32275
   PubMed Web of Science ®Google Scholar
• Ekins S, Schuetz E. The PXR crystal structure: The end of the beginning. Trends in Pharmacology Science 2002; 23: 49–50
   PubMed Web of Science ®Google Scholar
• Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, Einarsson C. Feedback regulation of bile acid synthesis in primary human hepatocytes: Evidence that CDCA is the strongest inhibitor. Hepatology 2003; 38: 930–938
   PubMed Web of Science ®Google Scholar
• Ellis E, Wagner M, Lammert F, Nemeth A, Gumhold J, Strassburg CP, Kylander C, Katsika D, Trauner M, Einarsson C, et al. Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin. Journal of Hepatology 2006; 44: 243–245
   PubMed Web of Science ®Google Scholar
• Eloranta JJ, Jung D, Kullak-Ublick GA. The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Molecular Endocrinology 2006; 20: 65–79
   PubMed Web of Science ®Google Scholar
• Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Archives in Biochemistry and Biophysics 2005a; 433: 397–412
   PubMed Web of Science ®Google Scholar
• Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Archives in Biochemistry and Biophysics 2005b; 433: 397–412
   PubMed Web of Science ®Google Scholar
• Espinoza J, Barnafi L, Schnaidt E. The effect of phenobarbital on intrahepatic cholestasis of pregnancy. American Journal of Obstetrics and Gynecology 1974; 119: 234–238
   PubMedGoogle Scholar
• Falany CN. Enzymology of human cytosolic sulfotransferases. FASEB Journal 1997; 11: 206–216
   PubMed Web of Science ®Google Scholar
• Fang C, Yoon S, Tindberg N, Jarvelainen HA, Lindros KO, Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochemistry and Pharmacology 2004; 67: 1389–1397
   PubMed Web of Science ®Google Scholar
• Fattinger K, Funk C, Pantze M, Weber C, Reichen J, Stieger B, Meier PJ. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions. Clinical Pharmacology and Therapy 2001; 69: 223–231
   PubMed Web of Science ®Google Scholar
• Feher T, Varadi A, Tanko A. Letter: Effect of spironolactone on blood bile-acid levels. Lancet ii 1976; 51
   Google Scholar
• Fickert P, Fuchsbichler A, Marschall HU, Wagner M, Zollner G, Krause R, Zatloukal K, Jaeschke H, Denk H, Trauner M. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. American Journal of Pathology 2006; 168: 410–422
   PubMed Web of Science ®Google Scholar
• Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, Krause R, Lammert F, Langner C, Zatloukal K, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004; 127: 261–274
   PubMed Web of Science ®Google Scholar
• Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, Lammert F, Stieger B, Meier PJ, Zatloukal K, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001; 121: 170–183
   PubMed Web of Science ®Google Scholar
• Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002; 123: 1238–1251
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pellicciari R, Morelli A. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 2004; 127: 1497–1512
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM, Sabatino G, Russo G, Castellani D, Willson TM, et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. Journal of Pharmacology and Experimental Therapy 2005a; 313: 604–612
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pruzanski M, Morelli A, Pellicciari R. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. Journal of Pharmacology and Experimental Therapy 2005b; 314: 584–595
   PubMed Web of Science ®Google Scholar
• Fischer S, Beuers U, Spengler U, Zwiebel FM, Koebe HG. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clinica et Chimica Acta 1996; 251: 173–186
   PubMed Web of Science ®Google Scholar
• Forker EL. The effect of estrogen on bile formation in the rat. Journal of Clinical Investigation 1969; 48: 654–663
   PubMed Web of Science ®Google Scholar
• Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687–693
   PubMed Web of Science ®Google Scholar
• Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 1998; 395: 612–615
   PubMed Web of Science ®Google Scholar
• Frankenberg T, Rao A, Chen F, Haywood J, Shneider BL, Dawson PA. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. American Journal of Physiology and Gastrointestinal Liver Physiology 2006; 290: G912–G922
   PubMed Web of Science ®Google Scholar
• Frohling W, Stiehl A. Bile salt glucuronides: Identification and quantitative analysis in the urine of patients with cholestasis. European Journal of Clinical Investigation 1976; 6: 67–74
   PubMed Web of Science ®Google Scholar
• Funk C, Ponelle C, Scheuermann G, Pantze M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Molecular Pharmacology 2001; 59: 627–635
   PubMed Web of Science ®Google Scholar
• Gall WE, Zawada G, Mojarrabi B, Tephly TR, Green MD, Coffman BL, Mackenzie PI, Radominska-Pandya A. Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. Journal of Steroid Biochemistry and Molecular Biology 1999; 70: 101–108
   PubMed Web of Science ®Google Scholar
• Gartung C, Ananthanarayanan M, Rahman MA, Schuele S, Nundy S, Soroka CJ, Stolz A, Suchy FJ, Boyer JL. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996; 110: 199–209
   PubMed Web of Science ®Google Scholar
• Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. Journal of Biology and Chemistry 2001; 276: 14581–14587
   PubMed Web of Science ®Google Scholar
• Geier A, Dietrich CG, Gerloff T, Haendly J, Kullak-Ublick GA, Stieger B, Meier PJ, Matern S, Gartung C. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochimica et Biophysica Acta 2003; 1609: 87–94
   PubMed Web of Science ®Google Scholar
• Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochimica et Biophysica Acta 2007; 1773: 283–308
   PubMed Web of Science ®Google Scholar
• Gerloff T, Geier A, Roots I, Meier PJ, Gartung C. Functional analysis of the rat bile salt export pump gene promoter. European Journal of Biochemistry 2002; 269: 3495–3503
   PubMedGoogle Scholar
• Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. Journal of Biology and Chemistry 1998; 273: 10046–10050
   PubMed Web of Science ®Google Scholar
• Ghent CN, Bloomer JR, Hsia YE. Efficacy and safety of long-term phenobarbital therapy of familial cholestasis. Journal of Pediatrics 1978; 93: 127–132
   PubMedGoogle Scholar
• Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988; 94: 488–493
   PubMed Web of Science ®Google Scholar
• Giguere V. Orphan nuclear receptors: From gene to function. Endocrinology Reviews 1999; 20: 689–725
   PubMed Web of Science ®Google Scholar
• Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes and Development 2000; 14: 121–141
   PubMed Web of Science ®Google Scholar
• Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocrinology Reviews 1994a; 15: 391–407
   PubMed Web of Science ®Google Scholar
• Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocrinology Reviews 1994b; 15: 391–407
   PubMed Web of Science ®Google Scholar
• Gong H, Singh SV, Singh SP, Mu Y, Lee JH, Saini SP, Toma D, Ren S, Kagan VE, Day BW, et al. Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells. Molecular Endocrinology 2006; 20: 279–290
   PubMed Web of Science ®Google Scholar
• Gong H, Xie W. Orphan nuclear receptors, PXR and LXR: New ligands and therapeutic potential. Expert Opinion in Therapy Targets 2004; 8: 49–54
   PubMed Web of Science ®Google Scholar
• Gong YZ, Everett ET, Schwartz DA, Norris JS, Wilson FA. Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol. Proceedings of the National Academy of Sciences. USA 1994; 91: 4741–4745
   PubMed Web of Science ®Google Scholar
• Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, Repa JJ. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proceedings of the National Academy of Sciences. USA 2003; 100: 223–228
   PubMed Web of Science ®Google Scholar
• Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Molecular Cell 2000; 6: 517–526
   PubMed Web of Science ®Google Scholar
• Goodwin B, Kliewer SA. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. American Journal of Physiology and Gastrointestinal Liver Physiology 2002; 282: G926–G931
   Google Scholar
• Goodwin B, Redinbo MR, Kliewer SA. Regulation of cyp3a gene transcription by the pregnane x receptor. Annual Reviews Pharmacology Toxicology 2002; 42: 1–23
   PubMed Web of Science ®Google Scholar
• Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996; 111: 193–198
   PubMed Web of Science ®Google Scholar
• Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, Ono T, Besnard P. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. Journal of Biology and Chemistry 1999; 274: 29749–29754
   PubMed Web of Science ®Google Scholar
• Gumucio JJ, Valdivieso VD. Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology 1971; 61: 339–344
   PubMedGoogle Scholar
• Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB, Jr, Kliewer SA, Gonzalez FJ, Sinal CJ. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. Journal of Biology and Chemistry 2003; 278: 45062–45071
   PubMed Web of Science ®Google Scholar
• Guo GL, Staudinger J, Ogura K, Klaassen CD. Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. Molecular Pharmacology 2002; 61: 832–839
   PubMed Web of Science ®Google Scholar
• Guzelian J, Barwick JL, Hunter L, Phang TL, Quattrochi LC, Guzelian PS. Identification of genes controlled by the pregnane X receptor by microarray analysis of mRNAs from pregnenolone 16alpha-carbonitrile-treated rats. Toxicology Science 2006; 94: 379–387
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. Journal of Clinical Investigation 1994; 93: 1326–1331
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochimica et Biophysica Acta 2003; 1609: 1–18
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family: Phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Archives 2004; 447: 653–665
   PubMed Web of Science ®Google Scholar
• Hagenbuch N, Reichel C, Stieger B, Cattori V, Fattinger KE, Landmann L, Meier PJ, Kullak-Ublick GA. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. Journal of Hepatology 2001; 34: 881–887
   PubMed Web of Science ®Google Scholar
• Handschin C, Meyer UA. Induction of drug metabolism: The role of nuclear receptors. Pharmacology Reviews 2003; 55: 649–673
   PubMed Web of Science ®Google Scholar
• Haussinger D, Schmitt M, Weiergraber O, Kubitz R. Short-term regulation of canalicular transport. Seminars in Liver Disease 2000; 20: 307–321
   PubMedGoogle Scholar
• Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997; 387: 733–736
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Maentausta O, Ylostalo P, Janne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. European Journal of Obstetrics. Gynecology and Reproductive Biology 1982; 14: 153–162
   PubMed Web of Science ®Google Scholar
• Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, Sugiyama Y. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Molecular Pharmacology 1998; 53: 1068–1075
   PubMed Web of Science ®Google Scholar
• Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). Journal of Biology and Chemistry 2000; 275: 2905–2910
   PubMed Web of Science ®Google Scholar
• Hofmann AF. Current concepts of biliary secretion. Digestive Disease Science 1989; 34: 16S–20S
   Google Scholar
• Hofmann AF. Biliary secretion and excretion in health and disease: Current concepts. Annals in Hepatology 2007; 6: 15–27
   PubMedGoogle Scholar
• Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochemistry Journal 2000; 347: 321–337
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Zelko I, Sueyoshi T, Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Molecular Cell Biology 1998; 18: 5652–5658
   PubMed Web of Science ®Google Scholar
• Hooiveld GJ, Vos TA, Scheffer GL, Van Goor H, Koning H, Bloks V, Loot AE, Meijer DK, Jansen PL, Kuipers F, et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats. Gastroenterology 1999; 117: 678–687
   PubMedGoogle Scholar
• Houten SM, Volle DH, Cummins CL, Mangelsdorf DJ, Auwerx J. In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue. Molecular Endocrinology 2007; 21: 1312–1323
   PubMedGoogle Scholar
• Hruz P, Zimmermann C, Gutmann H, Degen L, Beuers U, Terracciano L, Drewe J, Beglinger C. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut 2006; 55: 395–402
   PubMedGoogle Scholar
• Huang L, Zhao A, Lew JL, Zhang T, Hrywna Y, Thompson JR, de Pedro N, Royo I, Blevins RA, Pelaez F, et al. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. Journal of Biology and Chemistry 2003a; 278: 51085–51090
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proceedings of the National Academy of Sciences. USA 2003b; 100: 4156–4161
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Moore DD. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. Journal of Clinical Investigation 2004; 113: 137–143
   PubMed Web of Science ®Google Scholar
• Huber RM, Murphy K, Miao B, Link JR, Cunningham MR, Rupar MJ, Gunyuzlu PL, Haws TF, Kassam A, Powell F, et al. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene 2002; 290: 35–43
   PubMed Web of Science ®Google Scholar
• Hwang ST, Urizar NL, Moore DD, Henning SJ. Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 2002; 122: 1483–1492
   PubMed Web of Science ®Google Scholar
• Inokuchi A, Hinoshita E, Iwamoto Y, Kohno K, Kuwano M, Uchiumi T. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. Journal of Biology and Chemistry 2001; 276: 46822–46829
   PubMed Web of Science ®Google Scholar
• Ismair MG, Stanca C, Ha HR, Renner EL, Meier PJ, Kullak-Ublick GA. Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatology Research 2003; 26: 343–347
   PubMed Web of Science ®Google Scholar
• Ismair MG, Stieger B, Cattori V, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick GA. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology 2001; 121: 1185–1190
   PubMed Web of Science ®Google Scholar
• Iwanaga T, Nakakariya M, Yabuuchi H, Maeda T, Tamai I. Involvement of bile salt export pump in flutamide-induced cholestatic hepatitis. Biology and Pharmacology Bulletin 2007; 30: 739–744
   PubMed Web of Science ®Google Scholar
• Iyanagi T, Emi Y, Ikushiro S. Biochemical and molecular aspects of genetic disorders of bilirubin metabolism. Biochimica et Biophysica Acta 1998; 1407: 173–184
   PubMed Web of Science ®Google Scholar
• Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210–211
   PubMed Web of Science ®Google Scholar
• Jacquemin E, Hadchouel M. Genetic basis of progressive familial intrahepatic cholestasis. Journal of Hepatology 1999; 31: 377–381
   PubMed Web of Science ®Google Scholar
• Jansen PL, Muller M, Sturm E. Genes and cholestasis. Hepatology 2001; 34: 1067–1074
   PubMed Web of Science ®Google Scholar
• Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning JH, Jager-Krikken A, Kuipers F, Stellaard F, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999; 117: 1370–1379
   PubMed Web of Science ®Google Scholar
• Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metabolism and Disposition 2006; 34: 1756–1763
   PubMed Web of Science ®Google Scholar
• Johnson DR, Habeebu SS, Klaassen CD. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2. Toxicology Science 2002; 66: 16–26
   PubMed Web of Science ®Google Scholar
• Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, et al. The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution. Molecular Endocrinology 2000; 14: 27–39
   PubMed Web of Science ®Google Scholar
• Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 2004a; 53: 78–84
   PubMed Web of Science ®Google Scholar
• Jung D, Fried M, Kullak-Ublick GA. Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. Journal of Biology and Chemistry 2002a; 277: 30559–30566
   PubMed Web of Science ®Google Scholar
• Jung D, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick GA. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. American Journal of Physiology and Gastrointestinal Liver Physiology 2004b; 286: G752–G761
   PubMed Web of Science ®Google Scholar
• Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, Kullak-Ublick GA. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. Journal of Biology and Chemistry 2001; 276: 37206–37214
   PubMed Web of Science ®Google Scholar
• Jung D, Kullak-Ublick GA. Hepatocyte nuclear factor 1 alpha: A key mediator of the effect of bile acids on gene expression. Hepatology 2003a; 37: 622–631
   PubMed Web of Science ®Google Scholar
• Jung D, Kullak-Ublick GA. Hepatocyte nuclear factor 1 alpha: A key mediator of the effect of bile acids on gene expression. Hepatology 2003b; 37: 622–631
   PubMed Web of Science ®Google Scholar
• Jung D, Mangelsdorf DJ, Meyer UA. Pregnane X receptor is a target of farnesoid X receptor. Journal of Biology and Chemistry 2006; 281: 19081–19091
   PubMed Web of Science ®Google Scholar
• Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ, Kullak-Ublick GA. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 2002b; 122: 1954–1966
   PubMed Web of Science ®Google Scholar
• Kamath PS. Clinical approach to the patient with abnormal liver test results. Mayo Clinic Proceedings 1996; 71: 1089–1094
   PubMedGoogle Scholar
• Kamisako T, Ogawa H. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. Journal of Gastroenterology and Hepatology 2005; 20: 1429–1434
   PubMed Web of Science ®Google Scholar
• Karpen SJ, Sun AQ, Kudish B, Hagenbuch B, Meier PJ, Ananthanarayanan M, Suchy FJ. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. Journal of Biology and Chemistry 1996a; 271: 15211–15221
   PubMedGoogle Scholar
• Karpen SJ, Sun AQ, Kudish B, Hagenbuch B, Meier PJ, Ananthanarayanan M, Suchy FJ. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. Journal of Biology and Chemistry 1996b; 271: 15211–15221
   PubMedGoogle Scholar
• Karpen SJ. Nuclear receptor regulation of hepatic function. Journal of Hepatology 2002; 36: 832–850
   PubMed Web of Science ®Google Scholar
• Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. Journal of Biology and Chemistry 2002; 277: 2908–2915
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Kakizaki S, Yoshinari K, Negishi M. Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Molecular Endocrinology 2000; 14: 1897–1905
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Molecular Cell Biology 1999; 19: 6318–6322
   PubMed Web of Science ®Google Scholar
• Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D, Kubitz R. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005; 41: 1160–1172
   PubMed Web of Science ®Google Scholar
• Keppler D, Kamisako T, Leier I, Cui Y, Nies AT, Tsujii H, Konig J. Localization, substrate specificity, and drug resistance conferred by conjugate export pumps of the MRP family. Advances in Enzyme Regulation 2000; 40: 339–349
   PubMedGoogle Scholar
• Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, Redder T, Shan B, Russell DW, Schwarz M. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Development in Cells 2002; 2: 713–720
   PubMed Web of Science ®Google Scholar
• Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267–276
   PubMed Web of Science ®Google Scholar
• Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C. Repression of farnesoid X receptor during the acute phase response. Journal of Biology and Chemistry 2003; 278: 8988–8995
   PubMed Web of Science ®Google Scholar
• King CD, Rios GR, Green MD, Tephly TR. UDP-glucuronosyltransferases. Current Drug Metabolism 2000; 1: 143–161
   PubMed Web of Science ®Google Scholar
• Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinal CJ, Guo GL, Gonzalez FJ, et al. Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. Journal of Biology and Chemistry 2003; 278: 17838–17844
   PubMed Web of Science ®Google Scholar
• Kitamura T, Jansen P, Hardenbrook C, Kamimoto Y, Gatmaitan Z, Arias IM. Defective ATP-dependent bile canalicular transport of organic anions in mutant. (TR–) rats with conjugated hyperbilirubinemia. Proceedings of the National Academy of Sciences, USA, 1990. 87: 3557–3561
   Google Scholar
• Kiuchi Y, Suzuki H, Hirohashi T, Tyson CA, Sugiyama Y. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Letters 1998; 433: 149–152
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism. Endocrinology Reviews 2002; 23: 687–702
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998; 92: 73–82
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 1992a; 355: 446–449
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 1992b; 358: 771–774
   PubMed Web of Science ®Google Scholar
• Klug A, Schwabe JW. Protein motifs 5. Zinc fingers. FASEB Journal 1995; 9: 597–604
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Sueyoshi T, Inoue K, Moore R, Negishi M. Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Molecular Pharmacology 2003; 64: 1069–1075
   PubMed Web of Science ®Google Scholar
• Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, Staels B, Kuipers F. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochemistry Journal 2003a; 369: 539–547
   PubMed Web of Science ®Google Scholar
• Kok T, Wolters H, Bloks VW, Havinga R, Jansen PL, Staels B, Kuipers F. Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse. Gastroenterology 2003b; 124: 160–171
   PubMed Web of Science ®Google Scholar
• Konig J, Cui Y, Nies AT, Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. Journal of Biology and Chemistry 2000; 275: 23161–23168
   PubMed Web of Science ®Google Scholar
• Konig J, Nies AT, Cui Y, Leier I, Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochimica et Biophysica Acta 1999a; 1461: 377–394
   PubMed Web of Science ®Google Scholar
• Konig J, Rost D, Cui Y, Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999b; 29: 1156–1163
   PubMed Web of Science ®Google Scholar
• Konig J, Rost D, Cui Y, Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999c; 29: 1156–1163
   PubMed Web of Science ®Google Scholar
• Konig J, Seithel A, Gradhand U, Fromm MF. Pharmacogenomics of human OATP transporters. Naunyn Schmiedebergs Archives in Pharmacology 2006; 372: 432–443
   PubMed Web of Science ®Google Scholar
• Koopen NR, Wolters H, Havinga R, Vonk RJ, Jansen PL, Muller M, Kuipers F. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat. Hepatology 1998; 27: 537–545
   PubMed Web of Science ®Google Scholar
• Koyama K, Takagi Y, Ito K, Sato T. Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. American Journal of Surgery 1981; 142: 293–299
   PubMed Web of Science ®Google Scholar
• Kramer W, Girbig F, Glombik H, Corsiero D, Stengelin S, Weyland C. Identification of a ligand-binding site in the Na+/bile acid cotransporting protein from rabbit ileum. Journal of Biology and Chemistry 2001a; 276: 36020–36027
   PubMed Web of Science ®Google Scholar
• Kramer W, Sauber K, Baringhaus KH, Kurz M, Stengelin S, Lange G, Corsiero D, Girbig F, Konig W, Weyland C. Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinity labeling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. Journal of Biology and Chemistry 2001b; 276: 7291–7301
   PubMedGoogle Scholar
• Krell H, Hoke H, Pfaff E. Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats. Gastroenterology 1982; 82: 507–514
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Beuers U, Fahney C, Hagenbuch B, Meier PJ, Paumgartner G. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology 1997a; 26: 991–997
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Beuers U, Fahney C, Hagenbuch B, Meier PJ, Paumgartner G. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology 1997b; 26: 991–997
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Glasa J, Boker C, Oswald M, Grutzner U, Hagenbuch B, Stieger B, Meier PJ, Beuers U, Kramer W, et al. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 1997c; 113: 1295–1305
   PubMedGoogle Scholar
• Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001; 120: 525–533
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004; 126: 322–342
   PubMed Web of Science ®Google Scholar
• Kurihara H, Sano N, Takikawa H. Biliary excretion of taurocholate, organic anions and vinblastine in rats with alpha-naphthylisothiocyanate-induced cholestasis. Journal of Gastroenterology and Hepatology 2005; 20: 1069–1074
   PubMedGoogle Scholar
• Kurihara T, Akimoto M, Abe K, Ishiguro H, Niimi A, Maeda A, Shigemoto M, Yamashita K, Yokoyama I, Suzuki Y. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clinical Therapy 1993; 15: 890–898
   PubMed Web of Science ®Google Scholar
• Kurihara T, Niimi A, Maeda A, Shigemoto M, Yamashita K. Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid. American Journal of Gastroenterology 2000; 95: 2990–2992
   PubMed Web of Science ®Google Scholar
• Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, Silverman S, Rosenfeld MG, Glass CK. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes and Development 1993; 7: 1423–1435
   PubMed Web of Science ®Google Scholar
• Kurz AK, Graf D, Schmitt M, Vom DS, Haussinger D. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 2001; 121: 407–419
   PubMedGoogle Scholar
• Landrier JF, Eloranta JJ, Vavricka SR, Kullak-Ublick GA. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. American Journal of Physiology and Gastrointestinal Liver Physiology 2006; 290: G476–G485
   PubMed Web of Science ®Google Scholar
• Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenetics and Genomics 2007; 17: 47–60
   PubMed Web of Science ®Google Scholar
• Lanzini A, De Tavonatti MG, Panarotto B, Scalia S, Mora A, Benini F, Baisini O, Lanzarotto F. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut 2003; 52: 1371–1375
   PubMed Web of Science ®Google Scholar
• Lazaridis KN, Pham L, Tietz P, Marinelli RA, deGroen PC, Levine S, Dawson PA, LaRusso NF. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. Journal of Clinical Investigation 1997; 100: 2714–2721
   PubMed Web of Science ®Google Scholar
• Lazaridis KN, Tietz P, Wu T, Kip S, Dawson PA, LaRusso NF. Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. Proceedings of the National Academy of Sciences. USA 2000; 97: 11092–11097
   PubMed Web of Science ®Google Scholar
• Lazaridis KN, Strazzabosco M, LaRusso NF. The cholangiopathies: Disorders of biliary epithelia. Gastroenterology 2004; 127: 1565–1577
   Google Scholar
• Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, Edwards PA. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. Journal of Lipid Research 2006; 47: 201–214
   PubMed Web of Science ®Google Scholar
• Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, Kramer W, Boyer JL. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 2001; 121: 1473–1484
   PubMed Web of Science ®Google Scholar
• Lee J, Boyer JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Seminars in Liver Disease 2000; 20: 373–384
   PubMed Web of Science ®Google Scholar
• Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000a; 118: 163–172
   PubMed Web of Science ®Google Scholar
• Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: Two mechanisms for repression. Molecular Cell Biology 2000b; 20: 187–195
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. Journal of Biology and Chemistry 1997; 272: 3137–3140
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation 1998; 102: 1016–1023
   PubMed Web of Science ®Google Scholar
• Leuschner U, Czygan P, Liersch M, Frohling W, Stiehl A. [Morphologic studies on the toxicity of sulfated and nonsulfated lithocholic acid in the isolation-perfused rat liver]. Zeitschrift für Gastroenterologie 1977; 15: 246–253
   PubMedGoogle Scholar
• Levy C, Lindor KD. Drug-induced cholestasis. Clinics in Liver Disease 2003; 7: 311–330
   PubMedGoogle Scholar
• Lew JL, Zhao A, Yu J, Huang L, de Pedro N, Pelaez F, Wright SD, Cui J. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. Journal of Biology and Chemistry 2004; 279: 8856–8861
   PubMedGoogle Scholar
• Li B, Wang Z, Fang JJ, Xu CY, Chen WX. Evaluation of prognostic markers in severe drug-induced liver disease. World Journal of Gastroenterology 2007; 13: 628–632
   PubMed Web of Science ®Google Scholar
• Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM, Karpen SJ. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. Journal of Biology and Chemistry 2002; 277: 31416–31422
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. American Journal of Physiology and Gastrointestinal Liver Physiology 2005; 288: G74–G84
   PubMed Web of Science ®Google Scholar
• Lickteig AJ, Slitt AL, Arkan MC, Karin M, Cherrington NJ. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metabolism and Disposition 2007; 35: 402–409
   PubMed Web of Science ®Google Scholar
• Liddle C, Goodwin B. Regulation of hepatic drug metabolism: Role of the nuclear receptors PXR and CAR. Seminars in Liver Disease 2002; 22: 115–122
   PubMed Web of Science ®Google Scholar
• Liu Q, Linney E. The mouse retinoid-X receptor-gamma gene: Genomic organization and evidence for functional isoforms. Molecular Endocrinology 1993; 7: 651–658
   PubMedGoogle Scholar
• Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. Journal of Clinical Investigation 2003; 112: 1678–1687
   PubMed Web of Science ®Google Scholar
• Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Molecular Cell 2000a; 6: 507–515
   PubMed Web of Science ®Google Scholar
• Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Molecular Cell 2000b; 6: 507–515
   PubMed Web of Science ®Google Scholar
• Luo G, Guenthner T, Gan LS, Humphreys WG. CYP3A4 induction by xenobiotics: Biochemistry, experimental methods and impact on drug discovery and development. Current Drug Metabolism 2004; 5: 483–505
   PubMed Web of Science ®Google Scholar
• Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994; 19: 480–488
   PubMed Web of Science ®Google Scholar
• Ma X, Shah Y, Cheung C, Guo GL, Feigenbaum L, Krausz KW, Idle JR, Gonzalez FJ. The PREgnane X receptor gene-humanized mouse: A model for investigating drug–drug interactions mediated by cytochromes P450 3A. Drug Metabolism and Disposition 2007; 35: 194–200
   PubMed Web of Science ®Google Scholar
• Maeda T, Miyata M, Yotsumoto T, Kobayashi D, Nozawa T, Toyama K, Gonzalez FJ, Yamazoe Y, Tamai I. Regulation of drug transporters by the farnesoid X receptor in mice. Molecular Pharmacology 2004; 1: 281–289
   Google Scholar
• Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Molecular Pharmacology 2002; 62: 638–646
   PubMed Web of Science ®Google Scholar
• Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metabolism and Disposition 2005; 33: 956–962
   PubMed Web of Science ®Google Scholar
• Makino I, Hashimoto H, Shinozaki K, Yoshino K, Nakagawa S. Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases. Gastroenterology 1975; 68: 545–553
   PubMed Web of Science ®Google Scholar
• Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 296: 1313–1316
   PubMed Web of Science ®Google Scholar
• Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362–1365
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes and Development 1992; 6: 329–344
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841–850
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–229
   PubMed Web of Science ®Google Scholar
• Mano Y, Usui T, Kamimura H. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2. Biopharmacology and Drug Disposition 2007; 28: 13–18
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wagner M, Bodin K, Zollner G, Fickert P, Gumhold J, Silbert D, Fuchsbichler A, Sjovall J, Trauner M. Fxr(–/–) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. Journal of Lipid Research 2006; 47: 582–592
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J, Silbert D, Fuchsbichler A, Benthin L, Grundstrom R, et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005b; 129: 476–485
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J, Silbert D, Fuchsbichler A, Benthin L, Grundstrom R, et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005a; 129: 476–485
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wagner M, Zollner G, Trauner M. Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors. Molecular Pharmacology, 2007; 4: 895–910
   PubMedGoogle Scholar
• McCarthy TC, Li X, Sinal CJ. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. Journal of Biology and Chemistry 2005; 280: 23232–23242
   PubMed Web of Science ®Google Scholar
• McGill JM, Yen MS, Cummings OW, Alpini G, LeSage G, Pollok KE, Miller B, Engle SK, Stansfield AP. Interleukin-5 inhibition of biliary cell chloride currents and bile flow. American Journal of Physiology and Gastrointestinal Liver Physiology 2001; 280: G738–G745
   Google Scholar
• Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997; 26: 1667–1677
   PubMed Web of Science ®Google Scholar
• Mennone A, Soroka CJ, Cai SY, Harry K, Adachi M, Hagey L, Schuetz JD, Boyer JL. Mrp4–/–mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 2006; 43: 1013–1021
   PubMed Web of Science ®Google Scholar
• Millatt LJ, Bocher V, Fruchart JC, Staels B. Liver X receptors and the control of cholesterol homeostasis: Potential therapeutic targets for the treatment of atherosclerosis. Biochimica et Biophysica Acta 2003; 1631: 107–118
   PubMed Web of Science ®Google Scholar
• Mita S, Suzuki H, Akita H, Hayashi H, Onuki R, Hofmann AF, Sugiyama Y. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs. Drug Metabolism and Disposition 2006; 34: 1575–1581
   PubMed Web of Science ®Google Scholar
• Miura N, Tanaka K. Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: Synergistic activation by HNF4 and HNF1 proteins. Nucleic Acids Research 1993; 21: 3731–3736
   PubMedGoogle Scholar
• Miyata M, Tozawa A, Otsuka H, Nakamura T, Nagata K, Gonzalez FJ, Yamazoe Y. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: A mechanism for protection against cholic acid-induced liver toxicity. Journal of Pharmacology and Experimental Therapy 2005; 312: 759–766
   PubMed Web of Science ®Google Scholar
• Modica S, Moschetta A. Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?. FEBS Letters 2006; 580: 5492–5499
   PubMed Web of Science ®Google Scholar
• Moore JT, Kliewer SA. Use of the nuclear receptor PXR to predict drug interactions. Toxicology 2000; 153: 1–10
   PubMed Web of Science ®Google Scholar
• Moore JT, Moore LB, Maglich JM, Kliewer SA. Functional and structural comparison of PXR and CAR. Biochimica et Biophysica Acta 2003; 1619: 235–238
   PubMed Web of Science ®Google Scholar
• Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert MH, Moore JT. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Molecular Endocrinology 2002; 16: 977–986
   PubMed Web of Science ®Google Scholar
• Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. Journal of Biology and Chemistry 2000; 275: 15122–15127
   PubMed Web of Science ®Google Scholar
• Moschetta A, vanBerge-Henegouwen GP, Portincasa P, Renooij WL, Groen AK, Van Erpecum KJ. Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: Potential implications for their effects in vivo. Journal of Hepatology 2001; 34: 492–499
   PubMedGoogle Scholar
• Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, Huang L, Yaramus M, Baum A, Venkataramanan R, et al. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. Journal of Pharmacology and Experimental Therapy 2006; 316: 1369–1377
   PubMed Web of Science ®Google Scholar
• Muller M. Transcriptional control of hepatocanalicular transporter gene expression. Seminars in Liver Disease 2000; 20: 323–337
   PubMed Web of Science ®Google Scholar
• Muller M, Jansen PL. The secretory function of the liver: New aspects of hepatobiliary transport. Journal of Hepatology 1998; 28: 344–354
   PubMed Web of Science ®Google Scholar
• Muscat GE, Wagner BL, Hou J, Tangirala RK, Bischoff ED, Rohde P, Petrowski M, Li J, Shao G, Macondray G, et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. Journal of Biology and Chemistry 2002; 277: 40722–40728
   PubMedGoogle Scholar
• Myant NB, Mitropoulos KA. Cholesterol 7 alpha-hydroxylase. Journal of Lipid Research 1977; 18: 135–153
   PubMed Web of Science ®Google Scholar
• Nagata T, Kanno Y, Ozato K, Taketo M. The mouse Rxrb gene encoding RXR beta: Genomic organization and two mRNA isoforms generated by alternative splicing of transcripts initiated from CpG island promoters. Gene 1994; 142: 183–189
   PubMedGoogle Scholar
• Nakai S, Masaki T, Kurokohchi K, Deguchi A, Nishioka M. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: A preliminary study. American Journal of Gastroenterology 2000; 95: 326–327
   PubMed Web of Science ®Google Scholar
• Narain PK, DeMaria EJ, Heuman DM. Lecithin protects against plasma membrane disruption by bile salts. Journal of Surgery Research 1998; 78: 131–136
   PubMed Web of Science ®Google Scholar
• Neimark E, Chen F, Li X, Shneider BL. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 2004; 40: 149–156
   PubMed Web of Science ®Google Scholar
• Nicolaou KC, Evans RM, Roecker AJ, Hughes R, Downes M, Pfefferkorn JA. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries. Organic and Biomolecular Chemistry 2003; 1: 908–920
   PubMed Web of Science ®Google Scholar
• Nishimura M, Koeda A, Suzuki E, Kawano Y, Nakayama M, Satoh T, Narimatsu S, Naito S. Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes. Drug Metabolism and Pharmacokinetics 2006; 21: 297–307
   PubMed Web of Science ®Google Scholar
• Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). Journal of Clinical Investigation 1997; 99: 1880–1887
   PubMed Web of Science ®Google Scholar
• Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K, Akizawa T, Yoshioka M, Sugiyama Y. Characterization of inducible nature of MRP3 in rat liver. American Journal of Physiology and Gastrointestinal Liver Physiology 2000; 278: G438–G446
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Mitsui Y, Yamamoto S. Effect of bezafibrate in primary biliary cirrhosis: A pilot study. Liver 2001; 21: 223–224
   PubMedGoogle Scholar
• Okada K, Shoda J, Kano M, Suzuki S, Ohtake N, Yamamoto M, Takahashi H, Utsunomiya H, Oda K, Sato K, et al. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. American Journal of Physiology and Gastrointestinal Liver Physiology 2007; 292: G1450–G1463
   PubMed Web of Science ®Google Scholar
• Okumura H, Katoh M, Sawada T, Nakajima M, Soeno Y, Yabuuchi H, Ikeda T, Tateno C, Yoshizato K, Yokoi T. Humanization of excretory pathway in chimeric mice with humanized liver. Toxicology Science 2007; 97: 533–538
   PubMed Web of Science ®Google Scholar
• Ordentlich P, Downes M, Evans RM. Corepressors and nuclear hormone receptor function. Current Topics in Microbiology and Immunology 2001; 254: 101–116
   PubMedGoogle Scholar
• Oswald M, Kullak-Ublick GA, Paumgartner G, Beuers U. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 2001; 21: 247–253
   PubMedGoogle Scholar
• Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, Remmel B, Voss H, Kaiser C, Albers M, et al. Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Molecular Cell Biology 2003; 23: 864–872
   PubMed Web of Science ®Google Scholar
• Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006; 130: 715–720
   PubMed Web of Science ®Google Scholar
• Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365–1368
   PubMed Web of Science ®Google Scholar
• Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: An overview. Seminars in Liver Disease 1998; 18: 105–114
   PubMed Web of Science ®Google Scholar
• Pauli-Magnus C, Meier PJ. Hepatocellular transporters and cholestasis. Journal of Clinical Gastroenterology 2005; 39: S103–S110
   PubMed Web of Science ®Google Scholar
• Paulusma CC, Kool M, Bosma PJ, Scheffer GL, ter Borg F, Scheper RJ, Tytgat GN, Borst P, Baas F, Oude Elferink RP. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin–Johnson syndrome. Hepatology 1997; 25: 1539–1542
   PubMed Web of Science ®Google Scholar
• Paulusma CC, Kothe MJ, Bakker CT, Bosma PJ, Van BI, Van Marle J, Bolder U, Tytgat GN, Oude Elferink RP. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 2000; 31: 684–693
   PubMed Web of Science ®Google Scholar
• Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World Journal of Gastroenterology 2006; 12: 4445–4451
   PubMedGoogle Scholar
• Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525–531
   PubMed Web of Science ®Google Scholar
• Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clinics in Liver Disease 2004; 8(vi)67–81
   PubMedGoogle Scholar
• Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93: 693–704
   PubMed Web of Science ®Google Scholar
• Pellicciari R, Costantino G, Camaioni E, Sadeghpour BM, Entrena A, Willson TM, Fiorucci S, Clerici C, Gioiello A. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure–activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. Journal of Medicine and Chemistry 2004; 47: 4559–4569
   PubMed Web of Science ®Google Scholar
• Pellicciari R, Fiorucci S, Camaioni E, Clerici C, Costantino G, Maloney PR, Morelli A, Parks DJ, Willson TM. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. Journal of Medicine and Chemistry 2002; 45: 3569–3572
   PubMed Web of Science ®Google Scholar
• Perlmann T, Rangarajan PN, Umesono K, Evans RM. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes and Development 1993; 7: 1411–1422
   PubMed Web of Science ®Google Scholar
• Petrick JS, Klaassen CD. Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metabolism and Disposition 2007; 35: 1806–1815
   PubMed Web of Science ®Google Scholar
• Pikuleva IA, Babiker A, Waterman MR, Bjorkhem I. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. Journal of Biology and Chemistry 1998; 273: 18153–18160
   PubMed Web of Science ®Google Scholar
• Pircher PC, Kitto JL, Petrowski ML, Tangirala RK, Bischoff ED, Schulman IG, Westin SK. Farnesoid X receptor regulates bile acid-amino acid conjugation. Journal of Biology and Chemistry 2003; 278: 27703–27711
   PubMed Web of Science ®Google Scholar
• Plass JR, Molecular O, Heegsma J, Geuken M, Faber KN, Jansen PL, Muller M. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 2002; 35: 589–596
   PubMed Web of Science ®Google Scholar
• Plebani M, Panozzo MP, Basso D, De Paoli M, Biasin R, Infantolino D. Cytokines and the progression of liver damage in experimental bile duct ligation. Clinical and Experimental Pharmacology and Physiology 1999; 26: 358–363
   PubMed Web of Science ®Google Scholar
• Podesta A, Lopez P, Terg R, Villamil F, Flores D, Mastai R, Udaondo CB, Companc JP. Treatment of pruritus of primary biliary cirrhosis with rifampin. Digestive Disease Science 1991; 36: 216–220
   PubMed Web of Science ®Google Scholar
• Priestly BG, Cote MG, Plaa GL. Biochemical and morphological parameters of taurolithocholate-induced cholestasis. Canadian Journal of Physiology and Pharmacology 1971; 49: 1078–1091
   PubMed Web of Science ®Google Scholar
• Prince MI, Burt AD, Jones DE. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut 2002; 50: 436–439
   PubMed Web of Science ®Google Scholar
• Raedsch R, Lauterburg BH, Hofmann AF. Altered bile acid metabolism in primary biliary cirrhosis. Digestive Disease Science 1981; 26: 394–401
   PubMed Web of Science ®Google Scholar
• Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metabolism Reviews 1997; 29: 413–580
   PubMed Web of Science ®Google Scholar
• Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: An estrogen-related disease. Seminars in Liver Disease 1993; 13: 289–301
   PubMed Web of Science ®Google Scholar
• Ritzel U, Leonhardt U, Nather M, Schafer G, Armstrong VW, Ramadori G. Simvastatin in primary biliary cirrhosis: Effects on serum lipids and distinct disease markers. Journal of Hepatology 2002; 36: 454–458
   PubMedGoogle Scholar
• Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. American Journal of Physiology and Gastrointestinal Liver Physiology 2006; 290: G640–G649
   Google Scholar
• Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003; 38: 374–384
   PubMed Web of Science ®Google Scholar
• Rizzo G, Renga B, Mencarelli A, Pellicciari R, Fiorucci S. Role of FXR in regulating bile acid homeostasis and relevance for human diseases. Current Drug Targets and Immune Endocrine and Metabolic Disorders 2005; 5: 289–303
   PubMedGoogle Scholar
• Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Journal of Clinical Investigation 1998; 101: 2790–2799
   PubMed Web of Science ®Google Scholar
• Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001; 120: 1459–1467
   PubMed Web of Science ®Google Scholar
• Ruetz S, Gros P. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 1994; 77: 1071–1081
   PubMed Web of Science ®Google Scholar
• Ruiz ML, Villanueva SS, Luquita MG, Ikushiro S, Mottino AD, Catania VA. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: Involvement of up-regulation of multidrug resistance-associated protein 2. Drug Metabolism and Disposition 2007; 35: 2060–2066
   PubMed Web of Science ®Google Scholar
• Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annual Reviews in Biochemistry 2003; 72: 137–174
   PubMed Web of Science ®Google Scholar
• Saini SP, Mu Y, Gong H, Toma D, Uppal H, Ren S, Li S, Poloyac SM, Xie W. Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology 2005; 41: 497–505
   PubMed Web of Science ®Google Scholar
• Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y, Ren S, Moore DD, Evans RM, Xie W. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Molecular Pharmacology 2004; 65: 292–300
   PubMed Web of Science ®Google Scholar
• Sauer P, Stiehl A, Fitscher BA, Riedel HD, Benz C, Kloters-Plachky P, Stengelin S, Stremmel W, Kramer W. Downregulation of ileal bile acid absorption in bile-duct-ligated rats. Journal of Hepatology 2000; 33: 2–8
   PubMedGoogle Scholar
• Savas U, Wester MR, Griffin KJ, Johnson EF. Rabbit pregnane X receptor is activated by rifampicin. Drug Metabolism and Disposition 2000; 28: 529–537
   PubMed Web of Science ®Google Scholar
• Scheffer GL, Kool M, de Haas M, De Vree JM, Pijnenborg AC, Bosman DK, Elferink RP, Van dV, Borst P, Scheper RJ. Tissue distribution and induction of human multidrug resistant protein 3. Laboratory Investigation 2002; 82: 193–201
   PubMed Web of Science ®Google Scholar
• Schuetz EG, Brimer C, Schuetz JD. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Molecular Pharmacology 1998; 54: 1113–1117
   PubMed Web of Science ®Google Scholar
• Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. Journal of Biology and Chemistry 2001; 276: 39411–39418
   PubMed Web of Science ®Google Scholar
• Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al. Role of LXRs in control of lipogenesis. Genes and Development 2000; 14: 2831–2838
   PubMed Web of Science ®Google Scholar
• Scotti E, Gilardi F, Godio C, Gers E, Krneta J, Mitro N, De Fabiani E, Caruso D, Crestani M. Bile acids and their signaling pathways: Eclectic regulators of diverse cellular functions. Cellular and Molecular Life Science 2007; 64: 2477–2491
   PubMedGoogle Scholar
• Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: Two novel orphan receptors. Molecular Endocrinology 1995; 9: 72–85
   PubMed Web of Science ®Google Scholar
• Seol W, Chung M, Moore DD. Novel receptor interaction and repression domains in the orphan receptor SHP. Molecular Cell Biology 1997; 17: 7126–7131
   PubMed Web of Science ®Google Scholar
• Seward DJ, Koh AS, Boyer JL, Ballatori N. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. Journal of Biology and Chemistry 2003; 278: 27473–27482
   PubMed Web of Science ®Google Scholar
• Sewnath ME, Van Der PT, Ten Kate FJ, Van Noorden CJ, Gouma DJ. Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxin. Hepatology 2002; 35: 149–158
   PubMedGoogle Scholar
• Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P. Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology 2002; 36: 451–455
   PubMed Web of Science ®Google Scholar
• Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, et al. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nature Genetics 2001; 27: 375–382
   PubMed Web of Science ®Google Scholar
• Shinka T, Inoue Y, Ohse M, Kuhara T. Simple and quantitative analysis of urinary sulfated tauro- and glycodihydroxycholic acids in infant with cholestasis by electrospray ionization mass spectrometry. Journal of Chromatography B:. Analytical Technology and Biomedical Life Science 2007; 855: 104–108
   PubMedGoogle Scholar
• Shneider BL, Dawson PA, Christie DM, Hardikar W, Wong MH, Suchy FJ. Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. Journal of Clinical Investigation 1995; 95: 745–754
   PubMed Web of Science ®Google Scholar
• Shneider BL, Fox VL, Schwarz KB, Watson CL, Ananthanarayanan M, Thevananther S, Christie DM, Hardikar W, Setchell KD, Mieli-Vergani G, et al. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology 1997; 25: 1176–1183
   PubMed Web of Science ®Google Scholar
• Shoda J, Miura T, Utsunomiya H, Oda K, Yamamoto M, Kano M, Ikegami T, Tanaka N, Akita H, Ito K, et al. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology 2004; 39: 167–178
   PubMed Web of Science ®Google Scholar
• Shulman AI, Mangelsdorf DJ. Retinoid x receptor heterodimers in the metabolic syndrome. New England Journal of Medicine 2005; 353: 604–615
   PubMed Web of Science ®Google Scholar
• Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. American Journal of Physiology 1996; 271: G1043–G1052
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731–744
   PubMed Web of Science ®Google Scholar
• Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, Van Deemter L, Molecular CA, Ottenhoff R, Van der Lugt NM, Van Roon MA. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451–462
   PubMed Web of Science ®Google Scholar
• Song C, Hiipakka RA, Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 2000; 65: 423–427
   PubMed Web of Science ®Google Scholar
• Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proceedings of the National Academy of Sciences. USA 2002; 99: 13801–13806
   PubMed Web of Science ®Google Scholar
• Soroka CJ, Lee JM, Azzaroli F, Boyer JL. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 2001; 33: 783–791
   PubMed Web of Science ®Google Scholar
• Squires EJ, Sueyoshi T, Negishi M. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. Journal of Biology and Chemistry 2004; 279: 49307–49314
   PubMed Web of Science ®Google Scholar
• Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metabolism and Disposition 2001a; 29: 1467–1472
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proceedings of the National Academy of Sciences. USA 2001b; 98: 3369–3374
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Madan A, Carol KM, Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metabolism and Disposition 2003; 31: 523–527
   PubMed Web of Science ®Google Scholar
• Stedman C, Liddle C, Coulter S, Sonoda J, Alvarez JG, Evans RM, Downes M. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proceedings of the National Academy of Sciences. USA 2006; 103: 11323–11328
   PubMed Web of Science ®Google Scholar
• Stedman C, Robertson G, Coulter S, Liddle C. Feed-forward regulation of bile acid detoxification by CYP3A4: Studies in humanized transgenic mice. Journal of Biology and Chemistry 2004; 279: 11336–11343
   PubMed Web of Science ®Google Scholar
• Stedman CA, Liddle C, Coulter SA, Sonoda J, Alvarez JG, Moore DD, Evans RM, Downes M. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proceedings of the National Academy of Sciences. USA 2005; 102: 2063–2068
   PubMed Web of Science ®Google Scholar
• Steinmetz AC, Renaud JP, Moras D. Binding of ligands and activation of transcription by nuclear receptors. Annual Reviews in Biophysical and Biomolecular Structures 2001; 30: 329–359
   PubMedGoogle Scholar
• Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000; 118: 422–430
   PubMed Web of Science ®Google Scholar
• Stiehl A, Becker M, Czygan P, Frohling W, Kommerell B, Rotthauwe HW, Senn M. Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: Effects of phenobarbital treatment. European Journal of Clinical Investigation 1980; 10: 307–316
   PubMed Web of Science ®Google Scholar
• Stiehl A, Raedsch R, Rudolph G, Gundert-Remy U, Senn M. Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients. Hepatology 1985; 5: 492–495
   PubMed Web of Science ®Google Scholar
• Stiehl A, Thaler MM, Admirand WH. Effects of phenobarbital on bile salt metabolism in cholestasis due to intrahepatic bile duct hypoplasia. Pediatrics 1973; 51: 992–997
   PubMedGoogle Scholar
• Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V, Gurakuqi G, Stauber RE, Marz W, Trauner M. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology 2007; 46: 776–784
   PubMedGoogle Scholar
• Strautnieks SS, Kagalwalla AF, Tanner MS, Knisely AS, Bull L, Freimer N, Kocoshis SA, Gardiner RM, Thompson RJ. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. American Journal of Human Genetics 1997; 61: 630–633
   PubMed Web of Science ®Google Scholar
• Stravitz RT, Sanyal AJ, Pandak WM, Vlahcevic ZR, Beets JW, Dawson PA. Induction of sodium-dependent bile acid transporter messenger RNA, protein, and activity in rat ileum by cholic acid. Gastroenterology 1997; 113: 1599–1608
   PubMedGoogle Scholar
• Stroup D, Crestani M, Chiang JY. Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. American Journal of Physiology 1997; 273: G508–G517
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. Journal of Biology and Chemistry 1999; 274: 6043–6046
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sugiyama Y. Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition. Advances in Drug Delivery Reviews 2002; 54: 1311–1331
   PubMed Web of Science ®Google Scholar
• Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nature Medicine 2001; 7: 584–590
   PubMed Web of Science ®Google Scholar
• Takeda S, Endo T, Aburada M. Pharmacological studies on iridoid compounds. III. The choleretic mechanism of iridoid compounds. Journal of Pharmacobiodynamics 1981; 4: 612–623
   PubMedGoogle Scholar
• Takikawa H, Otsuka H, Beppu T, Seyama Y, Yamakawa T. Serum concentrations of bile acid glucuronides in hepatobiliary diseases. Digestion 1983; 27: 189–195
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Chen J, Cooper AD. Regulation of cholesterol 7 alpha-hydroxylase gene expression in Hep-G2 cells. Effect of serum, bile salts, and coordinate and noncoordinate regulation with other sterol-responsive genes. Journal of Biology and Chemistry 1994; 269: 10071–10078
   PubMed Web of Science ®Google Scholar
• Tateno C, Yoshizane Y, Saito N, Kataoka M, Utoh R, Yamasaki C, Tachibana A, Soeno Y, Asahina K, Hino H, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. American Journal of Pathology 2004; 165: 901–912
   PubMed Web of Science ®Google Scholar
• Teng S, Jekerle V, Piquette-Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metabolism and Disposition 2003; 31: 1296–1299
   PubMed Web of Science ®Google Scholar
• Teng S, Piquette-Miller M. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. Journal of Pharmacology and Experimental Therapy 2005; 312: 841–848
   PubMed Web of Science ®Google Scholar
• Teng S, Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. British Journal of Pharmacology 2007; 151: 367–376
   PubMed Web of Science ®Google Scholar
• Thomassen PA. Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy. European Journal of Clinical Investigation 1979; 9: 425–432
   PubMed Web of Science ®Google Scholar
• Tian JM, Schibler U. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes and Development 1991; 5: 2225–2234
   PubMed Web of Science ®Google Scholar
• Timsit YE, Negishi M. CAR and PXR: The xenobiotic-sensing receptors. Steroids 2007; 72: 231–246
   PubMed Web of Science ®Google Scholar
• Tochtrop GP, DeKoster GT, Covey DF, Cistola DP. A single hydroxyl group governs ligand site selectivity in human ileal bile acid binding protein. Journal of the American Chemistry Society 2004; 126: 11024–11029
   PubMed Web of Science ®Google Scholar
• Torchia EC, Cheema SK, Agellon LB. Coordinate regulation of bile acid biosynthetic and recovery pathways. Biochemistry and Biophysics Research Communications 1996; 225: 128–133
   PubMedGoogle Scholar
• Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. Journal of Clinical Investigation 1998a; 101: 2092–2100
   PubMed Web of Science ®Google Scholar
• Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255–264
   PubMed Web of Science ®Google Scholar
• Trauner M, Boyer JL. Bile salt transporters: Molecular characterization, function, and regulation. Physiology Reviews 2003; 83: 633–671
   PubMed Web of Science ®Google Scholar
• Trauner M, Fickert P, Zollner G. Genetic disorders and molecular mechanisms in cholestatic liver disease — a clinical approach. Seminars in Gastrointestinal Disease 2001; 12: 66–88
   PubMedGoogle Scholar
• Trauner M, Graziadei IW. Review article: Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacology and Therapy 1999; 13: 979–996
   PubMed Web of Science ®Google Scholar
• Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. New England Journal of Medicine 1998b; 339: 1217–1227
   PubMed Web of Science ®Google Scholar
• Trauner M, Meier PJ, Boyer JL. Molecular regulation of hepatocellular transport systems in cholestasis. Journal of Hepatology 1999; 31: 165–178
   PubMed Web of Science ®Google Scholar
• Trauner M, Wagner M, Fickert P, Zollner G. Molecular regulation of hepatobiliary transport systems: Clinical implications for understanding and treating cholestasis. Journal of Clinical Gastroenterology 2005; 39: S111–S124
   PubMed Web of Science ®Google Scholar
• Tsai MJ, O’Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Reviews in Biochemistry 1994; 63: 451–486
   PubMed Web of Science ®Google Scholar
• Turncliff RZ, Meier PJ, Brouwer KL. Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 2004; 32: 834–839
   PubMed Web of Science ®Google Scholar
• Tzameli I, Pissios P, Schuetz EG, Moore DD. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Molecular Cell Biology 2000; 20: 2951–2958
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: Implications for interindividual variability in response to drugs. Journal of Clinical Pharmacology 2007; 47: 566–578
   PubMed Web of Science ®Google Scholar
• Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O, Zatloukal K, Guo GL, Schuetz JD, Gonzalez FJ, et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003; 125: 825–838
   PubMed Web of Science ®Google Scholar
• Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 2005; 42: 420–430
   PubMed Web of Science ®Google Scholar
• Wang DQ, Tazuma S, Cohen DE, Carey MC. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: Studies in the gallstone-susceptible mouse. American Journal of Physiology and Gastrointestinal Liver Physiology 2003; 285: G494–G502
   Google Scholar
• Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Molecular Cell 1999; 3: 543–553
   PubMed Web of Science ®Google Scholar
• Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS, Chua SS, Wei P, Heyman RA, Karin M, et al. Redundant pathways for negative feedback regulation of bile acid production. Development in Cells 2002; 2: 721–731
   PubMed Web of Science ®Google Scholar
• Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, Helgason CD, Ackerley C, Phillips MJ, Ling V. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proceedings of the National Academy of Sciences. USA 2001; 98: 2011–2016
   PubMed Web of Science ®Google Scholar
• Watkins RE, Noble SM, Redinbo MR. Structural insights into the promiscuity and function of the human pregnane X receptor. Current Opinions in Drug Discovery and Development 2002; 5: 150–158
   PubMed Web of Science ®Google Scholar
• Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR. The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity. Science 2001; 292: 2329–2333
   PubMed Web of Science ®Google Scholar
• Waxman DJ. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Archives in Biochemistry and Biophysics 1999; 369: 11–23
   PubMed Web of Science ®Google Scholar
• Whiting JF, Green RM, Rosenbluth AB, Gollan JL. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 1995; 22: 1273–1278
   PubMed Web of Science ®Google Scholar
• Wietholtz H, Marschall HU, Sjovall J, Matern S. Stimulation of bile acid 6 alpha-hydroxylation by rifampin. Journal of Hepatology 1996; 24: 713–718
   PubMed Web of Science ®Google Scholar
• Wilson FA, Burckhardt G, Murer H, Rumrich G, Ullrich KJ. Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro. Journal of Clinical Investigation 1981; 67: 1141–1150
   PubMed Web of Science ®Google Scholar
• Wolters H, Elzinga BM, Baller JF, Boverhof R, Schwarz M, Stieger B, Verkade HJ, Kuipers F. Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice. Journal of Hepatology 2002; 37: 556–563
   PubMed Web of Science ®Google Scholar
• Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Structural Biology 1996; 3: 87–94
   PubMedGoogle Scholar
• Wyde ME, Bartolucci E, Ueda A, Zhang H, Yan B, Negishi M, You L. The environmental pollutant 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor. Molecular Pharmacology 2003; 64: 474–481
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-Tetri BA, Brunt EM, Guzelian PS, Evans RM. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000; 406: 435–439
   PubMed Web of Science ®Google Scholar
• Xie W, Evans RM. Orphan nuclear receptors: The exotics of xenobiotics. Journal of Biology and Chemistry 2001; 276: 37739–37742
   PubMed Web of Science ®Google Scholar
• Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, Waxman DJ, Evans RM. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proceedings of the National Academy of Sciences. USA 2001; 98: 3375–3380
   PubMed Web of Science ®Google Scholar
• Xie W, Uppal H, Saini SP, Mu Y, Little JM, Radominska-Pandya A, Zemaitis MA. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discovery Today 2004; 9: 442–449
   PubMed Web of Science ®Google Scholar
• Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS, Cabrera GY, Tukey RH, Evans RM. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proceedings of the National Academy of Sciences. USA 2003; 100: 4150–4155
   PubMed Web of Science ®Google Scholar
• Xiong H, Yoshinari K, Brouwer KL, Negishi M. Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metabolism and Disposition 2002; 30: 918–923
   PubMed Web of Science ®Google Scholar
• Xu G, Pan LX, Li H, Forman BM, Erickson SK, Shefer S, Bollineni J, Batta AK, Christie J, Wang TH, et al. Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. Journal of Biology and Chemistry 2002; 277: 50491–50496
   PubMedGoogle Scholar
• Yang Y, Zhang M, Eggertsen G, Chiang JY. On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: Roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha. Biochimica et Biophysica Acta 2002; 1583: 63–73
   PubMedGoogle Scholar
• Yano K, Kato H, Morita S, Takahara O, Ishibashi H, Furukawa R. Is bezafibrate histologically effective for primary biliary cirrhosis?. American Journal of Gastroenterology 2002; 97: 1075–1077
   PubMed Web of Science ®Google Scholar
• Yin J, Miller M, Wennberg RP. Induction of hepatic bilirubin-metabolizing enzymes by the traditional Chinese medicine yin zhi huang. Development in Pharmacology Therapy 1991; 16: 176–184
   PubMedGoogle Scholar
• Yoshinari K, Kobayashi K, Moore R, Kawamoto T, Negishi M. Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Letters 2003; 548: 17–20
   PubMed Web of Science ®Google Scholar
• Yu J, Lo JL, Huang L, Zhao A, Metzger E, Adams A, Meinke PT, Wright SD, Cui J. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. Journal of Biology and Chemistry 2002; 277: 31441–31447
   PubMed Web of Science ®Google Scholar
• Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG. RXR beta: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991; 67: 1251–1266
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Nezasa K, Tian X, Bridges AS, Lee K, Belinsky MG, Kruh GD, Brouwer KL. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3–/–and Abcc4–/–mice. Journal of Pharmacology and Experimental Therapy 2006; 319: 1485–1491
   PubMed Web of Science ®Google Scholar
• Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ER. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994; 372: 635–641
   PubMed Web of Science ®Google Scholar
• Zechel C, Shen XQ, Chen JY, Chen ZP, Chambon P, Gronemeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO Journal 1994; 13: 1425–1433
   PubMed Web of Science ®Google Scholar
• Zelcer N, Reid G, Wielinga P, Kuil A, Van dH, I, Schuetz JD, Borst P. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochemistry Journal 2003; 371: 361–367
   PubMed Web of Science ®Google Scholar
• Zelcer N, Van de WK, de Waart R, Scheffer GL, Marschall HU, Wielinga PR, Kuil A, Kunne C, Smith A, Van dV, et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. Journal of Hepatology 2006; 44: 768–775
   PubMed Web of Science ®Google Scholar
• Zelko I, Sueyoshi T, Kawamoto T, Moore R, Negishi M. The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Molecular Cell Biology 2001; 21: 2838–2846
   PubMed Web of Science ®Google Scholar
• Zeng H, Liu G, Rea PA, Kruh GD. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Research 2000; 60: 4779–4784
   PubMed Web of Science ®Google Scholar
• Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W, Yan B. Rat pregnane X receptor: Molecular cloning, tissue distribution, and xenobiotic regulation. Archives in Biochemistry and Biophysics 1999; 368: 14–22
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang W, Chua SS, Wei P, Moore DD. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002; 298: 422–424
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang W, Qatanani M, Evans RM, Moore DD. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. Journal of Biology and Chemistry 2004a; 279: 49517–49522
   PubMed Web of Science ®Google Scholar
• Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, et al. The human pregnane X receptor: Genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 2001; 11: 555–572
   PubMedGoogle Scholar
• Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): Roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. Journal of Biology and Chemistry 2001; 276: 41690–41699
   PubMed Web of Science ®Google Scholar
• Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355: 441–446
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kast-Woelbern HR, Edwards PA. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. Journal of Biology and Chemistry 2003a; 278: 104–110
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kast-Woelbern HR, Edwards PA. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. Journal of Biology and Chemistry 2003b; 278: 104–110
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kast-Woelbern HR, Edwards PA. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. Journal of Biology and Chemistry 2003c; 278: 104–110
   PubMed Web of Science ®Google Scholar
• Zhang Z, Burch PE, Cooney AJ, Lanz RB, Pereira FA, Wu J, Gibbs RA, Weinstock G, Wheeler DA. Genomic analysis of the nuclear receptor family: New insights into structure, regulation, and evolution from the rat genome. Genome Research 2004b; 14: 580–590
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Fuchsbichler A, Silbert D, Wagner M, Arbeiter S, Gonzalez FJ, Marschall HU, Zatloukal K, Denk H, et al. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. Journal of Hepatology 2003a; 39: 480–488
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, Trauner M. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. Journal of Hepatology 2003b; 38: 717–727
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Silbert D, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H, Trauner M. Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. American Journal of Physiology and Gastrointestinal Liver Physiology 2002; 282: G184–G191
   Google Scholar
• Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001b; 33: 633–646
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001a; 33: 633–646
   PubMed Web of Science ®Google Scholar
• Zollner G, Marschall HU, Wagner M, Trauner M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: Pathogenetic and therapeutic considerations. Molecular Pharmacology 2006a; 3: 231–251
   PubMed Web of Science ®Google Scholar
• Zollner G, Wagner M, Fickert P, Geier A, Fuchsbichler A, Silbert D, Gumhold J, Zatloukal K, Kaser A, Tilg H, et al. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. American Journal of Physiology and Gastrointestinal Liver Physiology 2005; 289: G798–G805
   Google Scholar
• Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K, Denk H, Trauner M. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver International 2007c; 27: 920–929
   PubMed Web of Science ®Google Scholar
• Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K, Denk H, Trauner M. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver International 2007b; 27: 920–929
   PubMed Web of Science ®Google Scholar
• Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K, Denk H, Trauner M. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver International 2007a; 27: 920–929
   PubMed Web of Science ®Google Scholar
• Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, Fuchsbichler A, Halilbasic E, Denk H, Marschall HU, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: Role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. American Journal of Physiology and Gastrointestinal Liver Physiology 2006c; 290: G923–G932
   PubMed Web of Science ®Google Scholar
• Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, Fuchsbichler A, Halilbasic E, Denk H, Marschall HU, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: Role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. American Journal of Physiology and Gastrointestinal Liver Physiology 2006b; 290: G923–G932
   PubMed Web of Science ®Google Scholar
• Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, Fuchsbichler A, Halilbasic E, Denk H, Marschall HU, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: Role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. American Journal of Physiology and Gastrointestinal Liver Physiology 2006d; 290: G923–G932
   PubMed Web of Science ®Google Scholar